Current Illinois CancerCare Clinical Trals

Colorectal Cancer


Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

EA2201 (JIT) (Suspended)

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer( Suspended)


Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

NRG-GI005 (Suspended)

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery (Suspended)


CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease

RAIN-3202 (JIT)

Milademetan in Advanced/​Metastatic Solid Tumors


Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors


Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer


Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Search Again

WordPress PopUp Plugin